Elevated expression of PTEN and expression of PLK1 have significantly aggravated the prognosis of pancreatic cancer patients, which suggests that PLK1 is a critical “signal informer” defining the clinical significance of PTEN expression. This evidence concerns the gene PTEN and pancreatic neoplasm.